SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: celeryroot.com who wrote (25837)9/29/1998 2:49:00 PM
From: bob zagorin  Respond to of 32384
 
I really like the deal. An 8% note is very good in today's high yield market. As a LGND investor, i'm betting on their management team and this gives them the room they need to execute their plan. If they're successful, they will be a profitable pharmaceutical in a year or two and, as such, the market will value them by a different yardstick. I''m sure Elan is betting on their success. They didn't do the deal just to lend money at 8%.



To: celeryroot.com who wrote (25837)9/29/1998 2:55:00 PM
From: growthvalue  Read Replies (3) | Respond to of 32384
 
Celeryroot, Thanks for the cogent exposition of why this is a good deal for Ligand shareholders. It's obvious that you think critically about your stock holdings.

GV